Concurrent high-intensity interval plus resistance training improves vascular health in breast cancer survivors with high chemotherapy exposure

高强度间歇训练联合阻力训练可改善接受大量化疗的乳腺癌幸存者的血管健康

阅读:1

Abstract

BACKGROUND: The aim was to determine the effects of 8 weeks of concurrent training of abbreviated high-intensity interval-training and low–load resistance training (CT(HIIT+RT)) on functional and structural vascular outcomes of breast cancer survivors with a history of high or low exposure to chemotherapy sessions. METHODS: Breast cancer survivor women (n = 21, 58.7 ± 8.7 years) were divided into high– (HV(chemo), n = 11) or low–volume chemotherapy groups (LV(chemo), n = 10). Pulse wave velocity (PWV) and carotid intima–media maximum (cIMT(max)) were the primary outcomes, while flow-mediated dilation (FMD), carotid intima–media average (cIMT(av)), baseline brachial artery diameter (D(base)), peak diameter (D(peak)), and one-repetition maximum tests for the biceps (1RM(bc)), shoulder (1RM(sp)), back (1RM(back)), and leg extension (1RM(Leg)) served as secondary outcomes. RESULTS: PWV decreased in the LV(chemo) group (∆˗1.64 m⋅s(− 1), p < 0.001) but not in the HV(chemo) group. cIMT(max) was reduced only in the HV(chemo) group (∆˗0.23 mm, p = 0.024). FMD was significantly increased in the HV(chemo) (∆+5.06%, p = 0.023) but not in the LV(chemo) group. HV(chemo) and LV(chemo) groups increased D(base) (∆+0.38 mm, p = 0.005; and ∆+0.16 mm, p < 0.0001) and D(peak) (∆+0.32 mm, p = 0.008; and ∆+0.12 mm, p < 0.0001). HV(chemo) and LV(chemo) groups increase 1RM(bc) (∆+2.3 kg; and ∆+2.09 kg), 1RM(sp) (∆+2.15 kg; and ∆+2.36 kg), 1RM(back) (∆+4.4 kg; and ∆+4.58 kg), and 1RM(Leg) (∆+6.15 kg; and ∆+5.27 kg), all p < 0.01. CONCLUSIONS: Eight weeks of CT(HIIT+RT) in women breast cancer survivors who received higher chemotherapy volume reduces cIMT(max), but increases FMD, D(base), D(peak), cardiorespiratory fitness, and muscle strength. Vascular improvements were partially observed in subjects with lower chemotherapy volumes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40659-026-00677-y.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。